Particle.news
Download on the App Store

Enhanced Games’ Las Vegas Debut Falls Short as Regulators Refuse Recognition

The prototype sports meet exposed limits to for‑profit drug‑enabled competition and left questions about health oversight, athlete eligibility, and investor confidence.

Overview

  • The inaugural Enhanced Games, held Sunday in Las Vegas, allowed invited athletes to use FDA‑approved but sports‑banned performance drugs under claimed medical supervision and paid prizes including a $1 million bonus for a world record.
  • Organizers reported one disputed world‑record swim by Kristian Gkolomeev and 22 personal bests, but several marquee events were won by athletes who said they competed drug‑free, undercutting the meet’s claim that enhancements would routinely shatter records.
  • World Anti‑Doping Agency and World Aquatics rejected the competition’s legitimacy and said performances will not count as official results, creating immediate eligibility and sanction risks for participating athletes.
  • Enhanced Group Inc. investors reacted sharply with the company’s stock tumbling roughly 45 percent after the weekend, even as organizers announced sponsorship claims and plans for annual editions.
  • Independent doctors and anti‑doping authorities warned that short‑term medical monitoring cannot rule out long‑term harms to hearts, livers, kidneys, and hormones, raising ethical and governance questions about commercializing human enhancement.